Work

Mature Results of a Prospective Trial of Rituximab in Patients (Pt) with Post Transplant Lymphoproliferative Disorder (PTLD) Unresponsive or Ineligible for Reduced Immunosuppression (RIS).

Year: 2006

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.2755.2755

Authors: Jeff P. Sharman, Donald E. Tsai, Clare J. Twist, Steven M. Horwitz, Carol D. Jones, Sandra J. Horning

Institutions: Stanford University, University of Pennsylvania

Language: English

Topic: Viral-associated cancers and disorders

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980196894

FWCI:

Cites:

Cited by: 1

Related to: 10